Biochemical Evaluation of Patients with Cancer-Associated Hypercalcemia
- 11 December 1980
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 303 (24), 1377-1383
- https://doi.org/10.1056/nejm198012113032401
Abstract
In 50 consecutive patients with cancer-associated hypercalcemia, we measured nephrogenous cyclic AMP, tubular phosphorus threshold, fasting calcium excretion, plasma 1,25-dihydroxyvitamin D, and immunoreactive parathyroid hormone as determined by four region-specific anitserums. Nephrogenous cyclic AMP excretion was elevated in 41 patients and suppressed in nine (means, 5.85 vs. 0.51 nmol per 100 ml of glomerular filtrate). There was no overlap between these groups.This publication has 21 references indexed in Scilit:
- Cytochemical Bioassay of Parathyroid HormoneJCI Insight, 1980
- The Importance of Circulating 1,25-Dihydroxyvitamin D in the Pathogenesis of Hypercalciuria and Renal-Stone Formation in Primary HyperparathyroidismNew England Journal of Medicine, 1980
- Nephrogenous Cyclic AMP as a Parathyroid Function TestNephron, 1979
- Direct resorption of bone by human breast cancer cells in vitroNature, 1978
- Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.JCI Insight, 1977
- Parathyroid hormone secretion in vivo. Demonstration of a calcium-independent nonsuppressible component of secretion.JCI Insight, 1976
- Human Parathyroid Hormone IMMUNOLOGICAL CHARACTERIZATION OF ANTIBODIES AGAINST A GLANDULAR EXTRACT AND THE SYNTHETIC AMINO-TERMINAL FRAGMENTS 1-12 AND 1-34 AND THEIR USE IN THE DETERMINATION OF IMMUNOREACTIVE HORMONE IN HUMAN SERAJCI Insight, 1974
- Immunoreactive Forms of Circulating Parathyroid Hormone in Primary and Ectopic HyperparathyroidismJCI Insight, 1974
- PSEUDOHYPERPARATHYROIDISMMedicine, 1966
- Case 27461New England Journal of Medicine, 1941